In our analysis, we observed COVID-19 patients with altered immune cell distributions and marker expression profiles, consistent with prior findings, as well as MAIT cells expressing high CD161 and B cells expressing high CD20 (Yu et al. 2021). Here, KLRB1 is linked to COVID-19.